We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[Detection of antigenic determinants of the major structural proteins of various mammalian type C retroviruses in the leukocytes of patients with hemoblastoses and in healthy donors by the ELISA method].
Using the enzyme-labelled antibodies it was shown that extracts from leukocytes of patients with leukemias and healthy donors contain antigenic determinants related to major virus protein of mammalian C type oncornaviruses SSV/SSAV, BaEV, FeLV and RLV. The highest antigen activity in patients was detected in the feline leukemia (FeLV) system, and the least one--in the system of murine leukemia (RLV). Common antigenic determinants of major virus protein of the viruses under study were detected in all groups of patients with haemoblastoses and healthy donors, but the amount of positive results was considerably higher in the group of patients as compared to that in the group of donors.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app